The 4th Annual European Statistical Forum is taking place on Monday, the 18th of November in Amsterdam, and CROS NT is going to play an important role in this year's conference as sponsor, chair and presenter.
This year's conference focuses on "Missing Data in Clinical Trials". The handling of missing data in clinical trials has become a crucial topic for clinical drug development in particular with respect to the regulatory process. New methodologies and techniques have emerged such as mixed-model repeated measures, multiple imputations, pattern-mixture models for longitudinal data as well as specific censoring rules and models for time to event data.
The European Statistical Forum is dedicated to the investigation, exploration as well as the handling and analysis of missing data in clinical trials by presenting state-of-the-art statistical methodology, real-life case studies of clinical trials showing how missing data can be handled and regulatory viewpoints.
Representing CROS NT on the speaker panel is Paolo Fina, Senior Statistician and Head of Medical Writing. Paolo has more than 20 years of experience in the pharmaceutical industry as a biostatistician and has been involved in a wide variety of studies - from clinical to pre-clinical- as well as an expert consultant on Bayesian models. His presentation covers "Accounting for Missing Values in Sample Size Calculations" which discusses how to derive the effective sample size of a longitudinal study using an MMRM model.
Chairing the European Statistical Forum is CROS NT CEO, Paolo Morelli, who is also a biostatistician by background. He has more than 15 years of experience as a statistician and Director of Biometrics in the pharmaceutical and CRO environment.
CROS NT's Director of Biostatistics, Lisa Comarella, sits on the Scientific Board of the European Statistical Forum.
The conference is intended for statisticians and professionals with a deep interest in the methodological and regulatory characteristics of missing data in clinical trials.
This event further demonstrates CROS NT's commitment to statistics and the vital role it plays in clinical trials and the drug development process. In 2013, CROS NT joined the International Year of Statistics cause, which is a group of 1,400 organizations in 111 countries promoting the importance of statistics around the world and in various industries.
The European Statistical Forum provides professionals with an opportunity to discuss statistical methodology among their peers and receive a certificate of attendance for training records.